THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $209,870 | -8.4% | 18,705 | -9.8% | 0.01% | -57.1% |
| Q4 2021 | $229,000 | +17.4% | 20,729 | +57.4% | 0.01% | +7.7% |
| Q3 2020 | $195,000 | -16.7% | 13,167 | +18.3% | 0.01% | -18.8% |
| Q2 2020 | $234,000 | +7.8% | 11,126 | +85.6% | 0.02% | -66.7% |
| Q3 2016 | $217,000 | -20.8% | 5,995 | -50.3% | 0.05% | +33.3% |
| Q2 2016 | $274,000 | -54.6% | 12,056 | -78.1% | 0.04% | -30.8% |
| Q3 2015 | $604,000 | – | 55,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |